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Abstract  
BACKGROUND: Neonatal jaundice is one of the main causes of the patient's admission in the neonatal period 
and is potentially linked to morbidity.  
AIM: This study aimed to determine the possible risk factors for neonatal jaundice. 
METHODS: We investigated the case of infants who were admitted to the neonatal department of Ziyaeian 
hospital and Imam Khomeini Hospital for jaundice. Simple random sampling was used to evaluate variables 
related to maternal and neonatal predisposing factors based on the medical records and clinical profiles. All 
variables in this study were analysed using SPSS software. 
RESULTS: In this study, about 200 mothers and neonates were examined. Our findings depicted that mother's 
WBC, Hb, PLT, and gestational age were associated with jaundice (P < 0.05). Furthermore, there were significant 
relationships between different degrees of bilirubin with TSH, T4 levels and G6PD (P < 0.05). In fact, TSH, T4 
levels and G6PD were found to be linked to neonatal hyperbilirubinemia. The risk factors for jaundice in our study 
population comprise some predisposing factors such as WBC, Hb, PLT, gestational age, TSH, and T4 levels, as 
well as G6PD. Neonates at risk of jaundice are linked to some maternal and neonatal factors that can provide 
necessary interventions to reduce the burden of the disease. Therefore, identification of associated factors can 
facilitate early diagnosis, and reduce subsequent complications. 
CONCLUSION: Neonatal jaundice should be considered as the main policy in all health care settings of the 
country. Therefore, identification of factors affecting the incidence of jaundice can be effective in preventing 
susceptible predisposing factors in newborns and high-risk mothers. 
 
 
 
 
 
 
Introduction 
 
Neonatal jaundice is a common event that 
occurs especially in the first week of birth [1] [2] [3] 
and is one of the most common causes of 
hospitalisation of the term and preterm neonates in 
neonatal wards [1]. Based on the present evidence, 
80% of premature infants have clinical symptoms, 
including yellowish skin and sclera, caused by serum 
bilirubin levels [4] [5]. Hyperbilirubinemia is a common 
disease that occurs especially in the first week of birth 
[1] [2] [3] and is one of the most common causes of 
hospitalisation of the term and preterm infants in 
neonatal hospitals [1]. It usually occurs on the second 
day of birth and is not usually harmful, and a self-
limiting condition, where disease usually improves 
without treatment after reaching the normal amount of 
bilirubin [6] [7], but very high levels of bilirubin may 
lead to kernicterus as permanent brain damage. 
Nevertheless, diagnosis of newborn jaundice and its 
management will play an important role in the health 
of newborns [8]. If jaundice lasts more than 14 days, it 
is called to be prolonged neonatal jaundice [6].  
An imbalance between bilirubin production 
and conjugation is the main mechanism of jaundice, 
which leads to an increase in bilirubin levels. This 
imbalance often occurs due to the immature liver and 
the rapid breakdown of red blood cells, which may be 
involved with several factors [9] [10] [11] [12]. 
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The indirect bilirubin value in the physiologic 
jaundice of the term neonates does not exceed 12 
mg/dL on the third day, and, this maximum increase 
reaches 15 mg/dL in preterm infants on the fifth day 
[13]. 
In physiologic jaundice, the maximum indirect 
bilirubin of infants who fed breast milk may be higher 
than those fed with skimmed milk (15-17 mg/dL 
versus 12 mg/dL); this higher level is probably due to 
the lower consumption of fluid by infants who are 
breastfeeding [14]. 
Jaundice on the first day of life is always 
pathologic, and urgent attention is needed to find its 
cause. Early jaundice is often due to hemolysis and 
internal haemorrhage (cephalohematoma, liver or 
spleen hematoma) or infection. Furthermore, jaundice 
is considered to be pathologic after two weeks and 
suggests direct hyperbilirubinemia [13] 
Jaundice is usually seen in newborns when the 
concentration of bilirubin reaches 5-10 mg/dl; 
however, it is seen as 2-3 mg/dl in adults. If the 
jaundice is observed, the total bilirubin should be 
measured to determine its severity. On the other 
hand, If the concentration in the newborn is more than 
5 in the first day of life or higher than 13 mg/dl in the 
following days, further studies are needed to 
determine the direct and indirect bilirubin value, blood 
group, Coombs test, CBC, Peripheral blood smear 
and reticulocytes count [13]. 
Identification of predisposing factors in the 
management of the disease is important [15] [16], 
there are a number of predisposing factors in the 
occurrence of this disease, including maternal 
diabetes, race, prematurity, height, polycythemia, 
male sex, cephalohematoma, medications, Trisomy 
21, weight loss, breastfeeding, delayed meconium 
passage and family history of jaundice [17] [18] [19] 
[20] [21]. The most common cause of jaundice can be 
ABO incompatibility. Rh incompatibility and type of 
delivery can be among the controversial factors. 
Furthermore, some factors may contribute to jaundice, 
such as congenital infections (Syphilis, CMV, rubella, 
toxoplasmosis), and age more than 25 years [22]. To 
the best of our knowledge, there were not many 
studies on the epidemiology of jaundice in Iran. 
On the other hand, there has also been no 
program for the prevention and management of 
jaundice. Regarding the importance of irreversible 
complications of hyperbilirubinemia and the 
prevention of these complications, the present study 
was aimed to investigate the predisposing factors 
(maternal and neonatal risk factors) in the incidence of 
jaundice in newborn infants admitted to Ziaeean 
medical centre. Identifying predisposing factors in 
predicting the occurrence and prevention of such risks 
in neonates is important to reduce the morbidity and 
mortality of hyperbilirubinemia. 
 
Material and Methods 
 
This cross-sectional study was conducted on 
207 neonates (<15 days) with hyperbilirubinemia (> 
15 mg/dL) admitted to Ziaeean and Imam Khomeini 
hospitals in Tehran from April 2010 to May 2016. 
All neonates were examined for neonatal 
jaundice risk factors. Neonates born with jaundice 
were selected based on the clinical outcomes of the 
neonates. Furthermore, data from medical records 
and interviews with mothers were collected by survey 
staff. A checklist including demographic information 
and other information was also provided. 
Maternal variables including blood group, RH, 
Gestational diabetes mellitus (GDM), familial history of 
diabetes, history of anemia and thalassemia minor, 
history of thyroid disease during and before 
pregnancy, history of birth of a newborn with jaundice, 
history of smoking during pregnancy, use of herbal 
medicines during pregnancy, history of perinatal 
infections (TORCH: syphilis, rubella, toxoplasmosis), 
CMV, CBC were evaluated in the current study. 
Neonatal variables included gender, the age of birth, 
birth season, birth weight, blood group and Rh. 
Hyperbilirubinemia was the criteria for 
entering this study. Also, exclusion criteria included 
incomplete medical records. However, 20% of the 
sample size was considered as additional samples in 
the current study.  
Finally, data were collected from medical 
records and questionnaires. All data were then 
analysed by using SPSS software version 19. In this 
study, all principles of the Helsinki Statement were 
considered as a statement of ethical principles for 
medical studies. It is worth noting that parents were 
informed about the study. 
20% of the extra sample size was added to 
prevent loss and withdrawal (N = 200). P is 
considered to be the first pregnancy in the formula, as 
reported previously (24 and 25). Thus, the sample 
size was calculated as 200 individuals: alfa = 0.05, Z1-
a/2= 1.961150776, d= 0.03, p= 0.96, n= 165. 
Data were collected by a questionnaire that 
was asked by the researcher from the patient. 
Moreover, a set of data was collected from medical 
records. Then, the data were analysed by SPSS 
software. Frequency was calculated for qualitative 
variables, while the mean, range and standard 
deviation were calculated for quantitative variables. 
The chi-square test was used to examine qualitative 
data, and t-test for non-dependent samples was used 
to study quantitative data. It should be noted that the 
P-value of < 0.05 was considered significant. 
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Results 
 
The mean age of the pregnancy (weekly) 
based on the level of bilirubin was shown in Table 1. 
The result of statistical analysis indicated that the 
gestational age was significantly related to jaundice (P 
= 0.003). 
Table 1: Evaluation of Blood Factors and Other Neonatal 
Factors in Different Levels of Bilirubin 
Bilirubin g/age b/w bili/ 
total 
bili/d Retic wbc/n hb/n mcv/n plt/n hct/n tsh/n t4/n 
 p-value 0.003 0.105 0.000 0.740 0.079 0.370 0.389 0.107 0.192 0.704 0.003 0.105 
10-
14.9 
Average  36.01 2727.84 9.75 0.50 0.03 11.82 15.14 98.44 290.59 40.22 4.96 8.98 
Deviation 
standard  
3.29 715.43 2.55 0.38 0.02 4.03 3.23 7.92 95.97 9.27 3.52 2.72 
15-
19.9 
Average 37.94 2896.29 16.24 0.50 0.03 10.70 15.67 99.61 299.48 40.85 3.88 8.74 
Deviation 
standard 
1.59 572.05 0.82 0.21 0.02 3.02 2.45 8.58 64.59 8.38 1.62 3.08 
20-
24.9 
Average 38.00 3250.00 19.25 0.38 0.03 8.90 16.83 102.58 341.33 48.24 1.80 10.45 
Deviation 
standard 
1.10 388.59 1.29 0.16 0.01 2.51 3.43 4.30 115.11 8.59 0.71 1.34 
Total Average 36.37 2769.62 11.04 0.49 0.03 11.56 15.28 98.75 293.49 40.56 4.75 8.97 
Deviation 
standard 
3.13 693.32 3.61 0.35 0.02 3.89 3.13 7.96 92.42 9.18 3.31 2.75 
 
Moreover, as shown in Table, the findings of 
the statistical analysis revealed that the birth weight of 
the infant was not significantly associated with the 
incidence of jaundice based on the bilirubin levels (P = 
0.105). 
Assessment of neonatal bilirubin based on the 
different bilirubin level revealed that total bilirubin had 
a significant relationship with jaundice (P = 0.000). 
Furthermore, there was no significant correlation 
between direct bilirubin with jaundice (P = 0.740). 
The average reticulocyte count of the infant 
indicated that the reticulocyte was not significantly 
associated with the incidence of jaundice at the 
different levels of bilirubin (P = 0.079). The mean of 
Hb regarding bilirubin level exhibited that Hb of 
neonate was strongly associated with jaundice (P = 
0.389). Evaluation of the mean of mcv by the level of 
bilirubin depicted that there was no significant 
difference in infant mcv in different levels of bilirubin 
(P = 0.107). 
The mean of PLT and WBC were markedly 
associated with jaundice (P = 0.192; (P = 0.370). The 
results of our study showed that the mean of Hct 
neonates had a significant correlation with 
hyperbilirubinemia (P = 0.704). 
Based on the findings, it was revealed that the 
TSH and T4 were significantly associated with 
jaundice (P = 0.003; P = 0.105). 
Table 2: Evaluation of Maternal Blood Groups in Different Ages 
of Bilirubin (bg/m) 
P = 0.1 Bilirubin Total 
10-14.9 15-19.9 20-24.9 
Bg/m A Number 44 9 1 54 
Percent 27.0% 29.0% 16.7% 27.0% 
Ab Number 13 7 0 20 
Percent 8.0% 22.6% 0% 10.0% 
B Number 36 8 1 45 
Percent 22.1% 25.8% 16.7% 22.5% 
O Number 70 7 4 81 
Percent 42.9% 22.6% 66.7% 40.5% 
Total Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
Also, there was no significant difference in the 
maternal blood group in the neonates with different 
levels of bilirubin (P = 0.1; Table 2). 
Our findings have revealed that there was no 
significant difference in maternal hematologic Rh 
among neonates with different levels of bilirubin (P = 
0.8; Table 3). 
Table 3: Evaluation of RH Blood Groups in Maternal Different 
Ages of Bilirubin (Rh/m) 
P = 0.8 Bilirubin Total 
10-14.9 15-19.9 20-24.9 
Rh/m Positive Number 126 24 4 154 
Percent 77.3% 77.4% 66.7% 77.0% 
Negative Number 37 7 2 46 
Percent 22.7% 22.6% 33.3% 23.0% 
Total Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
Based on Table 4, out of 163 patients, 41 
neonates (25.2%), who their mothers suffered from 
GDM, exhibited a serum bilirubin level of 10-14.9, 
followed by a bilirubin level of 20-24.9 (16.7%) and a 
bilirubin level of 15-19.9 (16.1%). Neonates with 
different levels of bilirubin exhibited no significant 
difference regarding gestational diabetes mellitus (P = 
0.5). 
Table 4: Evaluation of Gestational Diabetes Mellitus in Different 
Ages of  Bilirubin 
P = 0.5 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Gestational 
diabetes 
mellitus 
(GDM) 
Yes 
Number 41 5 1 47 
Percent 25.2% 16.1% 16.7% 23.5% 
No 
Number 122 26 5 153 
Percent 74.8% 83.9% 83.3% 76.5% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
In the present study, out of 163 neonates, 72 
patients (44.2%) with a history of familial diabetes 
revealed bilirubin levels of 10 to 14.9, following a 
bilirubin level of 15-19.9 (54.8%) and a bilirubin level 
of 20-24.9 (16.7%), (Table 5). No significant difference 
was found in the familiar history of diabetes among 
neonates with different levels of bilirubin (P = 0.2). As 
a matter of fact, familial history of diabetes was not 
found to be correlated with hyperbilirubinemia. 
Table 5: Evaluation of Familiar Diabetes Mellitus in Different 
Ages of  Bilirubin 
P=0.2 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Familiar/dm 
Yes 
Number 72 17 1 90 
Percent 44.2% 54.8% 16.7% 45.0% 
No 
Number 91 14 5 110 
Percent 55.8% 45.2% 83.3% 55.0% 
Total Number 163 31 
6 200 
 
 
Table 6 indicated that out of 163 neonates 35 
newborns (21.5%) with a maternal history of anaemia 
showed the bilirubin level of 10-14.9, following a 
bilirubin level of 15-19.9 (32.3%) and a bilirubin level 
of 20-24.9 (33.3%). There was no significant 
difference in the maternal history of anaemia between 
neonates with different levels of bilirubin (P = 0.3). 
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Table 6: Evaluation of Maternal Anemia in Different Ages of  
Bilirubin 
 P = 0.3 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Anaemia 
Yes 
Number 35 10 2 47 
Percent 21.5% 32.3% 33.3% 23.5% 
No 
Number 128 21 4 153 
Percent 78.5% 67.7% 66.7% 76.5% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
Bilirubin levels of 10-14.9% were seen in 
9.2% of neonates with maternal thalassemia, followed 
by a bilirubin level of 15-19.9 (22.6%) and a bilirubin 
level of 20-24.9 (0%), (Table 7). The maternal 
thalassemia was not associated with different levels of 
bilirubin (P = 0.06). 
Table 7: Evaluation of Maternal Thalcemia in Different Ages of 
Bilirubin 
P = 0.06 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Thalassemia 
Yes 
Number 15 7 0 22 
Percent 9.2% 22.6% 0% 11.0% 
No 
Number 148 24 6 178 
Percent 90.8% 77.4% 100.0% 89.0% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
We also found that the baby's blood group 
was not significantly related to Hyperbilirubinemia 
(P=0.3l Table 8), followed by a bilirubin level of 15-
19.9 in 80.6% of RH
+
 infants and bilirubin levels of 20-
24.9 in 66.7% of Rh
+
 infants. 
Table 8: Evaluation of Neonatal  Blood Groups in Different 
Ages of Bilirubin 
P = 0.3 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
 
A 
Number 58 7 1 66 
Percent 35.6% 22.6% 16.7% 33.0% 
AB 
Number 20 7 0 27 
Percent 12.3% 22.6% 0% 13.5% 
B 
Number 41 6 2 49 
Percent 25.2% 19.4% 33.3% 24.5% 
O 
Number 44 11 3 58 
Percent 27.0% 35.5% 50.0% 29.0% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
Based on the data presented in Table 9, it 
was found that the RH blood group was not related to 
hyperbilirubinemia (P = 0.7). 
Table 9: Evaluation of RH Blood Groups in Neonatal Different 
Ages of  Bilirubin (Rh/m) 
P = 0.7 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Rh/n 
Positive 
Number 128 25 4 157 
Percent 78.5% 80.6% 66.7% 78.5% 
Negative 
Number 35 6 2 43 
Percent 21.5% 19.4% 33.3% 21.5% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
As shown in Table 10, out of 163 patients, 50 
neonates (30.7%) with asphyxia showed a bilirubin 
level of 10-14.9, following a bilirubin level of 15-19.9 
(3.2%). There was no significant difference in 
asphyxia among newborns with different levels of 
bilirubin (P = 0.002). In other words, asphyxia was not 
associated with hyperbilirubinemia. 
Table 10: Evaluation of Asphyxia in Neonatal Different Ages of  
Bilirubin 
P=0.002 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Asphyxia 
Yes 
Number 50 1 0 51 
Percent 30.7% 3.2% 0% 25.5% 
No 
Number 113 30 6 149 
Percent 69.3% 96.8% 100.0% 74.5% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
According to Table 11, 15.5% of neonates 
showed cephalohematoma, while 84.5% of them did 
not show this complication. Of the total number of 163 
neonates, 13.5% of neonates with hematoma showed 
a bilirubin level of 10-14.9, while bilirubin levels of 19-
15 and 20-24.9 were found in 25.8% and 16.7% of 
neonates, respectively. Findings demonstrated that 
there was no significant relationship between 
cephalohematoma and disease (P = 0.2, Table 10). In 
the present study, G6PD was also related to the 
disease (P = 0.02). 
Table 11: Evaluation of Cephalohematoma in Neonatal 
Different Ages of Bilirubin 
P = 0.2 
Bilirubin 
Total 
10-14.9 15-19.9 20-24.9 
Cephalohematoma 
Yes 
Number 22 8 1 31 
Percent 13.5% 25.8% 16.7% 15.5% 
No 
Number 141 23 5 169 
Percent 86.5% 74.2% 83.3% 84.5% 
Total 
Number 163 31 6 200 
Percent 100.0% 100.0% 100.0% 100.0% 
 
 
 
Discussion 
 
Recent studies have demonstrated neonatal 
jaundice occurrence in more than 60% of term and 
80% of premature neonates in the first week, where 
bilirubin is non-conjugate, lipid-soluble, and non-polar 
pigment. Bilirubin is one of the final products of 
haemoglobin catabolism and its clinical significance in 
the neonates is due to sedimentation in the skin and 
mucous membrane and the formation of jaundice.  
This complication is also the most common 
cause of hospitalisation of the neonates in the first 
month after birth (about 19%). In most cases, jaundice 
can be transient, usually resolved by the end of the 
first week after birth, when the total serum bilirubin 
concentration is not considered to be a harmful 
condition. Severe hyperbilirubinemia has been 
described to develop with a potential risk for acute 
bilirubin encephalopathy and kernicterus [23] [24] [25] 
[26] [27] [28] [32] [33] [34] [35] [36] [37]. Neonatal 
jaundice usually starts from the face and progresses 
with the increase in the serum level to the abdomen 
and legs. Based data described before, Jaundice is 
one of the most common neonatal problems [23] [24] 
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[25] [26] [27] [28] [29]. 
This complication may lead to death in the first 
months, and infants who are still alive often suffer from 
mental retardation, movement and balance disorders, 
seizures, hearing loss at high frequencies, and speech 
impairment. Therefore, the timely diagnosis and 
treatment of neonatal jaundice are very important in 
preventing its complications. Identifying the 
predisposing factors of neonatal jaundice is still a 
serious discussion and can be effective in controlling 
jaundice and controlling the primary problem. In the 
natural state, since liver enzymes have not evolved 
enough, some icterus appears on the second to third 
day, reaching its maximum on the second to fourth day 
and decreasing on the fifth to seventh days. This type 
of jaundice is called physiologic jaundice. Factors such 
as maternal diabetes, race, premature infant, 
medication use of mother, male gender, 
cephalohaematoma, breastfeeding, weight loss, 
delayed stools in the baby may be correlated with 
physiologic jaundice [23] [24] [25] [26] [27] [28] [29] 
[30]. We also evaluated neonates for jaundice -specific 
risk association such as gestational age, birth weight 
gestational diabetes, familial history of diabetes, low 
birth weight, maternal history of anemia, maternal 
thalassemia, asphyxia, cephalohematoma, TSH and T4 
and related blood factors including, blood count (Hb, 
Hct. MCV. WBC and PLT) maternal-fetal blood group 
and their Rh for potential risks. 
The result of our study indicated that the 
gestational age was significantly linked to jaundice. 
Consist of our study; It has been described that the 
risk of hyperbilirubinemia significantly increases with 
decreasing gestational age [31] [32] [33] [34] [35]. 
Furthermore, weight loss in the neonatal period is 
considered as another risk factor for jaundice [35] 
[36]. Low-calorie intake has been indicated to be 
associated with increased hepatic circulation of 
bilirubin and often occurs within the first few days 
before milk comes in [35] [36] [37]; however, we didn’t 
find a significant association of birth weight with the 
incidence of jaundice. Based on the evidence present 
in literature, neonates with low gestational age (less 
than 37 weeks) and increased level of bilirubin in the 
first hours of life should be evaluated to confirm and 
monitor them adequately. Also, rapid diagnosis of low 
birth weight infants with or without visual evidence of 
weight loss at admission is needed to be included into 
clinical guideline for the control of neonatal 
hyperbilirubinemia [38]. Another known risk factors 
identified in different investigations for the 
development of jaundice in neonates such as Asian 
race, birth weight, exclusive breastfeeding, difficulty 
feeding, male sex, labour with oxytocin, primiparity, 
etc., [39] [40] [41] [42] [43] [44]. 
Risk factors identified in different 
investigations for the development of jaundice in 
neonates among blood count variables, the mean of 
Hb, Hct, PLT and WBC were found to be markedly 
associated with hyperbilirubinemia in the present 
study. However, our findings have revealed that 
maternal and neonatal blood group and RH were not 
significantly associated with hyperbilirubinemia 
A previous study indicated that blood type and 
Rh incompatibilities had been the important causes of 
kernicterus [45]. It has been depicted that ABO 
incompatibility, idiopathic jaundice, G6PD deficiency 
and Rh incompatibility be the most important 
predisposing factors for acute kernicterus [45]. 
Based on the data presented in the current 
study, G6PD was also related to the disease. While 
the exact mechanism for linking G6PD deficiency to 
hyperbilirubinemia is still not fully understood, early 
diagnosis of G6PD deficiency in infants can 
adequately reduce the risk of hyperbilirubinemia in 
affected neonates [40] [46], indicating the importance 
of prevention and timely treatment due to the 
incompatibility of ABO and Rh. According to the 
recommendations of the WHO Working Group, 
screening for all neonates should be performed in 
areas with a prevalence of 3-5% for G6PD deficiency 
[47]. It is worth noting that the incompatibility of the 
blood group can be managed through daily care and 
the diagnosis of mothers whose neonates are at risk 
for these disorders [40][48]. 
 A study indicated that the main causes of the 
high prevalence of Jaundice complications in icteric 
newborns include incomplete follow-up in acrylic 
babies due to ABO incompatibility, physician 
insensitivity, lack of routine examination of neonatal 
babies born to mothers with type O (Rh+) and 
parental insensitivity [49].  
Our data demonstrated that gestational 
diabetes mellitus was not linked to hyperbilirubinemia. 
Also family history of diabetes was not observed to be 
associated with hyperbilirubinemia. 
A study has reported that gestational diabetes 
has various and dangerous side effects on the baby, 
the most common being neonatal jaundice (3.7%), 
[50]. It is also described that the incidence of neonatal 
jaundice in diabetic mothers is three times higher than 
that in the control group. Perhaps the reason for the 
difference in the prevalence of maternal diabetes 
associated- jaundice in different studies could be due 
to differences in study type and sample size [51]. In 
the current study, the maternal thalassemia and 
anaemia were not found to be associated with 
neonatal jaundice. However, further studies are 
needed to clarify the role of maternal thalassemia and 
anaemia in the development of hyperbilirubinemia. It 
is worth noting that anaemia may range from 
asymptomatic to life-threatening and reported to 
potentially be linked to severe hyperbilirubinemia [52]. 
Patients with haemoglobin H has been indicated to 
usually born with hypochromic anaemia, where may 
be at high risk for neonatal hyperbilirubinemia [53] 
[54]. Also, Based on our findings, cephalohematoma 
and asphyxia were not observed to be significantly 
linked to hyperbilirubinemia. 
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Neonatal asphyxia can inhibit the activity of 
uridine diphosphate glucuronyltransferase (UDPGT) in 
the liver, consequently increasing the level of 
unconjugated bilirubin. Cephalohematoma or 
ecchymosis can lead to extravascular hemolysis, 
consequently increasing the level of bilirubin. 
A study believed that infants' asphyxia could 
inhibit the activity of uridine diphosphate 
glucuronyltransferase (UDPGT) in the liver, leading to 
an increase in unconjugated bilirubin. 
Cephalohematoma may be associated with vascular 
hemolysis, resulting in elevated levels of bilirubin [55]. 
A study found no relationship between thyroid 
hormones (iodine deficiency) and jaundice [56]. 
However, more detailed studies are needed to 
evaluate the role of thyroid hormones on jaundice. 
In the present study, it was revealed that the 
TSH and T4 were significantly correlated with the 
occurrence of jaundice. Our study has shown that 
high TSH increases the likelihood of jaundice (global 
statistics also indicate this); therefore, paediatricians 
are more interested in conducting TSH tests on the 
fifth day of birth and comparing with the level of 
bilirubin. The risk factors for jaundice in our study 
population comprise some predisposing Factors such 
as WBC, Hb, PLT, gestational age, TSH, and T4 
levels, as well as G6PD. Our study may be helpful in 
explaining the relationship between some of the 
predisposing factors with newborn jaundice to provide 
more evidence for managing disease in hospitals. 
Evaluation of risk factors for neonatal 
hyperbilirubinemia is important because high risk 
factors play an important role in neonatal jaundice in a 
Hospital. Large-scale studies are also needed for 
further and also by the control group. Since the 
promotion of neonatal health as a vulnerable group in 
the health care services has a special place, so the 
evaluation of neonatal jaundice in all levels of health 
services should be considered as a fundamental 
policy. 
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